Keyphrases
Breast Cancer
100%
Liposomes
100%
Doxorubicin
100%
Gemcitabine
100%
Immunostimulatory
100%
Phosphoinositide Lipid
100%
Tumor
33%
Triple-negative Breast Cancer
33%
Rechallenge
33%
Cancer Therapy
16%
Tumor Growth
16%
Toll-like Receptor 4 (TLR4)
16%
Molar Ratio
16%
Breast Cancer Treatment
16%
Dendritic Cells
16%
Rapid Growth
16%
CD86
16%
Cellular Expression
16%
Tumor-infiltrating Lymphocytes
16%
Breast Cancer Subtypes
16%
Pegylated Liposomal Doxorubicin
16%
Primary Tumor Growth
16%
Immune Modulating Agents
16%
Tumor Immune Microenvironment
16%
Lipid Bilayer
16%
Lipooligosaccharide
16%
Immune Evasion
16%
Long-term Immune Response
16%
4T1 Tumor
16%
Medicine and Dentistry
Breast Cancer
100%
Doxorubicin
100%
Gemcitabine
100%
Liposome
100%
Phosphoryl Lipid A
100%
Neoplasm
50%
Tumor Progression
33%
Triple Negative Breast Cancer
33%
Toll Like Receptor 4
16%
Immune Response
16%
In Vitro
16%
Cancer Therapy
16%
Immunotherapy
16%
Dendritic Cell
16%
Immunity
16%
Primary Tumor
16%
Tumor Infiltrating Lymphocyte
16%
Immune Evasion
16%
Tumor Immune Microenvironment
16%
Lipid Bilayer
16%
Immunology and Microbiology
Phosphoryl Lipid A
100%
Immunity
33%
Immune Response
16%
Dendritic Cell
16%
Immunotherapy
16%
CD86
16%
TLR4
16%
Immune Evasion
16%
Tumor-Associated Macrophage
16%
Lipid Bilayer
16%